Aerogen Pharma

Executive Summary

Aerogen Pharma is a specialty pharmaceutical company focused on developing inhaled therapeutics using its proprietary aerosol delivery technology. As the drug development arm of the Aerogen Group, the global leader in high-performance nebulizers, the company leverages patented enhancements to hospital-grade devices to improve pulmonary drug delivery. Currently in Phase 3, Aerogen Pharma targets unmet needs in respiratory diseases. With operations in Ireland and the US, the company combines deep inhalation expertise with a proven platform, positioning itself for potential regulatory milestones and commercialization.

Upcoming Catalysts (preview)

• Q4 2026Phase 3 Topline Data for Lead Inhaled Candidate65% success
• Q1 2027Strategic Partnership or Licensing Deal for Non-Respiratory Indications50% success
• Q2 2026FDA Meeting or Breakthrough Therapy Designation in Respiratory Disease40% success